2009 annual financial data
Rigel Pharmaceuticals 2009 Operating margin
Direct answer
Operating margin was -14,938.27%.
Operating income was -112,037,000 USD and net income was -111,547,000 USD.
Operating cash flow was -102,779,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 750,000 USD
- Operating income
- -112,037,000 USD
- Net income
- -111,547,000 USD
- Operating cash flow
- -102,779,000 USD